16 ASX shares that doubled in value last year

S&P/ASX All Ordinaries Index (ASX: XAO) shares rose by 7.55% last year and delivered total gross returns, including dividends, of 11.44%. The index closed the year at 8,420.5 points.

In comparison, the benchmark S&P/ASX 200 Index (ASX: XJO) lifted 7.49%, with total gross returns also coming in at 11.44%. The ASX 200 finished the year at 8,159.1 points.

Multiple ASX All Ords stocks delivered exceptional price growth in 2024. We provide a sample of these multi-bagger stocks below.

Here are 16 ASX shares that shot the lights out with a minimum doubling in stock price over the year.

16 ASX shares that more than doubled in value last year

1. Mesoblast Ltd (ASX: MSB)

ASX biotech share Mesoblast skyrocketed by 900% to close at $3.10 apiece on 31 December.

2. Zip Co Ltd (ASX: ZIP)

This ASX financial stock ripped in 2024 with the Zip share price soaring 352.5% to close at $2.96.

3. Appen Ltd (ASX: APX)

ASX tech share Appen catapulted 319.1% higher to close at $2.64 on 31 December.

4. IperionX Ltd (ASX: IPX)

This materials share soared 295.68% to finish the year at $5.50 per share.

5. Nuix Limited (ASX: NXL) 

The Nuix share price rocketed 232.63% higher in 2024 to close at $6.32 per share on 31 December.

6. Superloop Ltd (ASX: SLC)

Shares in ASX telecommunications company SuperLoop streaked 226.87% higher to $2.19.

7. Life360 Inc (ASX: 360)

Stock in social tracking app developer Life360 rose by 198.15% to finish the year at $22.54 per share.

8. Spartan Resources Ltd (ASX: SPR)

The Spartan Resources share price rose by 171.15% in 2024. The ASX gold mining share closed the year at $1.41 apiece.

9. Ora Banda Mining Ltd (ASX: OBM)

Fellow gold mining stock Ora Banda lifted 170.83% to close the year at 65 cents per share.

10. Catapult Group International Ltd (ASX: CAT)

Shares in sports technology solutions provider Catapult lifted 169% to $3.71 over the 12 months.

11. Sigma Healthcare Ltd (ASX: SIG)

ASX healthcare share Sigma leapt 162% higher to close at $2.62 on 31 December.

12. Pro Medicus Limited (ASX: PME)

The Pro Medicus share price rose by 161% to finish 2024 at $250.12 per share.

13. Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix Pharmaceuticals share price shot 144.14% higher to close at $24.61 on 31 December.

14. Pinnacle Investment Management Group Ltd (ASX: PNI)

The Pinnacle Investment share price rose 126.69% to finish at $22.85 on 31 December.

15. Clarity Pharmaceuticals Ltd (ASX: CU6)

This ASX biopharmaceutical share rocketed 120.6% to close out the year at $4.17.

16. TechnologyOne Ltd (ASX: TNE)

TechnologyOne shares ascended 103.71% to close 2024 at $31.31 per share.

The post 16 ASX shares that doubled in value last year appeared first on The Motley Fool Australia.

Motley Fool contributor Bronwyn Allen has positions in Appen, Mesoblast, and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Appen, Catapult Group International, Life360, Pinnacle Investment Management Group, Technology One, Telix Pharmaceuticals, and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has recommended Catapult Group International, Nuix, Pro Medicus, Technology One, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2025